Big Idea Ventures Reveals the Latest Cohort of Its Alternative Protein Accelerator
Big Idea Ventures selected 17 startups working in the alternative protein sector for the latest cohort of its accelerator. The...
Read moreDetailsBig Idea Ventures selected 17 startups working in the alternative protein sector for the latest cohort of its accelerator. The...
Read moreDetailsCurrently underway, the 2022 Daring Cities forum is seeing experts, researchers, practitioners and urban leaders address climate financing for cities...
Read moreDetailsCuba saw a landslide vote in favour of legalising same-sex marriage, alongside a slew of other changes to the constitutional...
Read moreDetailsMedtech and pharmaceutical company Qnovia just completed a $17 Million Series A round led by Blue Ledge Capital. Other investors...
Read moreDetailsFood scarcity is a deep-rooted, global issue that has been exacerbated by the climate crisis and Covid-19 pandemic. After gradually...
Read moreDetails
Impakter keeps you informed through its ESG news platform and empowers your business through the Impakter Index.
To assess and improve your company’s ESG performance, explore Klimado’s ESG dashboard and assessment tools at www.klimado.com.
Registered Office Address
Klimado GmbH
Niddastrasse 63,
60329, Frankfurt am Main, Germany
IMPAKTER is a Klimado GmbH website
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2026 IMPAKTER. All rights reserved.